Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 7, 2013, Pages

  Usmani, Zafar A ^a,b   Carson, Kristin V ^a,b   Heslop, Karen ^c   Esterman, Adrian J ^d   De Soyza, Anthony ^e   Smith, Brian J ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; ARTICLE; ASSERTIVE TRAINING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COGNITIVE BEHAVIORAL THERAPY; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL DISEASE; HUMAN; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHODYNAMIC PSYCHOTHERAPY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT PLANNING;

EID: 85015730904     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010673     Document Type: Article

References (46)

1. Altman DG, Bland JM. Statistics notes. Units of analysis. BMJ 1997;314:1874.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
3. Beck AT, Steer RA. Beck Anxiety Inventory: A Manual. 2nd Edition. San Antonio, TX: Psychological Corporation, 1993.
4. Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis. Patient Education and Counseling 2011;83:29-36. [DOI: ]
5. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561-71.
6. Beck JG, Scott SK, Teague RB, Perez LI, Brown GA. Correlates of daily impairment in COPD. Rehabilitation Psychology 1988;33:77-84.
7. Borg GA. Psychophysical basis of perceived exertion. Medicine and Science in Sports and Exercise 1982;14:377-81.
8. Borson S, Claypoole K, McDonald GJ. Depression and chronic obstructive pulmonary disease: treatment trials. Seminars in Clinical Neuropsychiatry 1998;3:115-30.
9. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact and treatment. Psychosomatic Medicine 2003;65:963-70.
10. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. British Medical Journal 1982;284 (6329):1607-8.
11. Campbell M, Grimshaw J, Steen N. Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action) Health Services Research Unit, University of Aberdeen, UK. Journal of Health Services Research and Policy Jan 2000;5(1):12-16.
12. Clark D. A cognitive approach to panic. Behavior Research and Therapy 1986;24:461-70.
13. Coventry P, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Journal of Psychosomatic Research 2007;63:551-65.
14. Davison GC, Neale JM. Abnormal Psychology. New York: John Wiley & Sons, 2003.
15. Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, et al.Influence of anxiety on health outcomes in COPD. Thorax 2010;65:229-34.
16. Global Initiative for Chronic Obstructive Lung Disease Inc. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/uploads/users/files/GOLD_AtAGlance:2013_Feb20.pdf (accessed 23 July 2013).
17. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al.Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. European Respiratory Journal 2005;26(3):414-9.
18. Zigmond AS, Snaith RP. The Hospital Anxiety And Depression Scale. Acta Psychiatrica Scandinavia 1983;67:361-70.
19. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons, 2011.
20. Jones PW, Quirk FH, Baveystock CM. The St Georges Respiratory Questionnaire. Respiratory Medicine 1991;85 (Suppl B):25-31.
21. Kandel ER. A new intellectual framework for psychiatry. American Journal of Psychiatry 1998;155:457-69.
22. Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9th Edition. Lippincott Williams & Wilkins (LWW), 2009.
23. Kim HF, Kuic ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, et al.Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000;41(6):465-71.
24. Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, et al.One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychological Medicine 2001;31:717-23.
25. Laurin C, Moullec G, Bacon SL, Lavoie KL. The impact of psychological distress on exacerbation rates in COPD. Therapeutic Advances in Respiratory Disease 2011;5(1):3-18. [DOI: ]
26. Ley R. Agoraphobia, the panic attack and the hyperventilation syndrome. Behaviour Research and Therapy 1985;23:79-81.
27. Livermore N, Sharpe L, McKenzie D. Panic attacks and panic disorder in chronic obstructive pulmonary disease: a cognitive behavioral perspective. Respiratory Medicine 2010;104(9):1246-53.
28. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al.Anxiety and depression in COPD. Chest October 2008;134:43S-53S.
29. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nordic Journal of Psychiatry 2004;58(1):65-70. [DOI: ]
30. Norweg AM, Whiteson J, Malgady R, Mola A, Rey M. The effectiveness of different combinations of pulmonary rehabilitation program components: a randomized controlled trial. Chest 2005;128:663-72.
31. Nutt DJ, Glue P, Lawsom CW, Wilson S. Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder. Archives of General Psychiatry 1999;47:917-25.
32. Perna G, Caldirola D, Bellodi L. Panic disorder: from respiration to the homeostatic brain. Acta Neuropsychiatrica 2004;16:57-67.
33. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al.Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2007;176:532-55.
34. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
35. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation of physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Annals of Internal Medicine 1995;122:823-32.
36. Rose C, Wallace L, Dickson R, Ayres J, Lehman R, Searle Y, et al.The most effective psychologically based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Patient Education and Counseling 2002;47:311-8. [PUBMED: 12135822]
37. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
38. Usmani ZA, Carson KV, Cheng JN, Esterman AJ, Smith BJ. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: ]
39. Usmani ZA, Carson KV, Labiszewski NA, Cheng JN, Esterman AJ, Smith BJ. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews in press.
40. Usmani ZA, Labiszewski NA, Carson KV, Cheng JN, Esterman AJ, Smith BJ. Psychological interventions for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews in press.
41. Viinamaki H, Kuikka J, Tiihonen J, Lehtonen J. Change in monoamine transporter density related to clinical recovery: a case control study. Nordic Journal of Psychiatry 1998;52:39-44.
42. Weaver TE, Richmond TS, Narsavage GL. An explanatory model of functional status in chronic obstructive pulmonary disease. Nursing Research 1997;46:26-31.
43. Willgoss T, Yohannes A, Goldbart J, Fatoye F. COPD and anxiety: its impact on patients' lives. Nursing Times 2011;107(15-16):16-9.
44. Wu HS, Wu SC, Lin JG, Lin LC. Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease. Journal of Advanced Nursing 2004;45(3):252-9.
45. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. International Journal of Geriatric Psychiatry 2000;15(12):1090-6.
46. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. International Journal of Geriatric Psychiatry 2001;16(5):451-4.